Thunder Bridge Acquisition, Ltd. TBRG 深 沪
已收盘 08-01 16:00:00 美东时间
20.54
-0.280
-1.34%
华盛通- 最 高20.69
- 今 开20.69
- 成交量 11.45万股
- 最 低 20.105
- 昨 收 20.82
- 总市值 3.09亿
- 52周最高 32.00
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 11.39
- 委 比 -87.34%
- 总股本 1502.34万
- 历史最高 32.00
- 量 比 0.69
- 振 幅 2.81%
- 历史最低 7.55
- 每 手 1
- 风险率 5.90%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多TruBridge Integrates Microsoft Dragon Copilot With Its EHR Solution To Enhance Care Delivery, Financial Stability, And Efficiency
TruBridge, Inc. (NASDAQ:TBRG), a leading healthcare solutions company, today announced the integration of Microsoft Dragon Copilot with its electronic health record (EHR) solution. Collaboration between the two
05-19 21:10
Earnings Scheduled For May 7, 2025
Companies Reporting Before The Bell • Wallbox (NYSE:WBX) is estimated to report...
05-07 16:33
美股大行评级 | 潜在涨幅506%！ JMP首予MBX Biosciences"跑赢大市"评级，目标价38美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1117373634651086848.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Canaccord Genuity：维持Travere Therapeutics(TVTX)"买入"评级，目标价从45美元升至47美元</p> <p>• JMP证券：维持Benitec生物制药(BNTC)"跑赢大市"评级，
04-11 09:36
Stephens & Co. Reiterates Equal-Weight on TruBridge, Maintains $28 Price Target
Stephens & Co. analyst Jeff Garro reiterates TruBridge (NASDAQ:TBRG) with a Equal-Weight and maintains $28 price target.
04-10 20:50
Stock selloff slashes needed-market cap for new Russell 2000 additions: Stephens
The market capitalization needed for companies to join the Russell 2000 Index (RTY) this year has nosedived as stocks have tumbled, according to investment advisory firm Stephens. New additions to th...
03-13 20:00
TruBridge, Inc. (TBRG): 2024年全年业绩显著提升，2025年计划推进全球劳动力战略
05.TruBridge, Inc. (TBRG)2024年第四季度财报电话会议：2024年，公司整体业绩显著提升，全年收入达3.39亿美元，调整后...
03-13 06:41
Gangtise投研日报 | 2025-03-13
来源：Gangtise投研 以下为3月12日热点题材的涨幅表现 制造 | 科技（5条） 01． AI算力分析师称，大模型行业规模...
03-13 06:30
美股大行评级 | 美银证券：维持雅培"买入"评级，目标价从133美元升至150美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1106501041932570625.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Roth MKM：维持CervoMed Inc.(CRVO)"买入"评级，目标价从7美元升至15美元</p> <p>• Oppenheimer：维持Trevi Therapeutics(TRVI)"跑赢大市"评级，目标价从
03-12 11:01
TruBridge Sees Q1 2025 Revenue $85M-$88M Vs $87.59M Est.; FY25 Revenue $345M-$360M Vs $355.976M Est.
Financial GuidanceFor the first quarter of 2025, TruBridge expects to generate:Total revenue between $85 million and $88 millionAdjusted EBITDA between $14 million and $16 millionFor the full year 2025, TruBridge expects
03-11 04:09
Earnings Scheduled For March 10, 2025
Companies Reporting Before The Bell • Franco-Nevada (NYSE:FNV) is expected to r...
03-10 16:32
